ARBs and Cancer Risk: New Meta-Analysis Raises Questions Again ARBs and Cancer Risk: New Meta-Analysis Raises Questions Again

The trial-level analysis suggests a dose-response relationship between exposure to angiotensin receptor blockers and the risk for cancer, reawakening previous questions on this issue.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Cardiology News Source Type: news